The Prevention of Failure to Rescue Using Early Warning Scoring

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

414 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-08-31

Study Completion Date

2010-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess if, compared with standard paper-based systems, an automated Early Warning System (EWS) resident in a spot check patient monitor, can help to identify deteriorating patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Warning System for Clinical Deterioration on General Hospital Wards

NCT01280942

Escalation of Care Cardiopulmonary Arrest Respiratory Arrest +2 more

COMPLETED NA

The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission

NCT05766319

Critically Ill ICU Survivor User Experience

COMPLETED NA

Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care

NCT02893462

Critical Illness

RECRUITING

Detecting Post-surgical Respiratory Compromise and Prompting Patients to Self-rescue: An Early Feasibility Study

NCT02962557

Anesthesia

ACTIVE_NOT_RECRUITING NA

Remote Cardiac Monitoring of Higher-Risk Emergency Department Syncope Patients After Discharge - A Pilot Study

NCT02786940

Syncope Arrhythmia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to assess if, compared with standard paper-based systems, an automated Early Warning System (EWS) resident in a spot check patient monitor, can help to identify patients in the acute care settings but outside of the intensive care unit, who may be experiencing physiological instability and who are in need of rapid clinical intervention by a Rapid Response Team (RRT)/ Medical Emergency Team (MET).

The development of such an automated system by offers a unique opportunity to assess its user-friendliness, labour-saving effect, feasibility and clinical utility. Accordingly, we plan to conduct a research program aimed at assessing this new approach toward patient monitoring.

This study will use the hospital's Standard of Care protocol for the monitoring of vital signs (including timing and vital signs collected) and a commercially available automatic spot check monitor to collect data. No investigational procedures or devices are associated with this protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis Renal Failure Pulmonary Edema Cardio-pulmonary Arrest

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Patients who triggered MET/RRT calls prior to the use of the MP5 EWS patient monitor.

use of the MP5 EWS patient monitor

Intervention Type DEVICE

All patients on the study ward receive the same care in Groups 1 and 2. The only difference is the device used to collect the vital signs. In Group 2, the MP5 EWS spot check monitor (FDA approved and CE marked) is the vital signs collection device.

Group 2

Patients who triggered MET/RRT calls after the use of the MP5 EWS patient monitor.

use of the MP5 EWS patient monitor

Intervention Type DEVICE

All patients on the study ward receive the same care in Groups 1 and 2. The only difference is the device used to collect the vital signs. In Group 2, the MP5 EWS spot check monitor (FDA approved and CE marked) is the vital signs collection device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

use of the MP5 EWS patient monitor

All patients on the study ward receive the same care in Groups 1 and 2. The only difference is the device used to collect the vital signs. In Group 2, the MP5 EWS spot check monitor (FDA approved and CE marked) is the vital signs collection device.

Intervention Type DEVICE